Lv11
36 积分 2023-11-30 加入
CAR-T for multiple myeloma: practice pearls
1小时前
已完结
Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm
18天前
已完结
Senescence-resistant human mesenchymal progenitor cells counter aging in primates
18天前
已完结
Small molecule and peptide-based CXCR4 modulators as therapeutic agents. A patent review for the period from 2010 to 2018
23天前
已完结
Clinical, tumor and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma
26天前
已完结
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
26天前
已完结
Honing CAR T cells to tackle acute myeloid leukemia
27天前
已完结
Interpreting the clinical outcomes to date for AML-directed CAR T cell therapies
27天前
已完结
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
1个月前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
2个月前
已完结
皖公网安备34019202002308
